ELFN1-AS1 plays an oncogenic role by binding to TAOK1 and preventing STK3 phosphorylation by TAOK1, thereby inhibiting the Hippo signaling pathway and promoting GC progression. This evidence concerns the gene TAOK1 and gastric cancer.